LV10953A - Aizvietotie benzimidazoli to iegusanas panemiens pielietojums farmaceitiska kompozicija - Google Patents
Aizvietotie benzimidazoli to iegusanas panemiens pielietojums farmaceitiska kompozicijaInfo
- Publication number
- LV10953A LV10953A LV931045A LV931045A LV10953A LV 10953 A LV10953 A LV 10953A LV 931045 A LV931045 A LV 931045A LV 931045 A LV931045 A LV 931045A LV 10953 A LV10953 A LV 10953A
- Authority
- LV
- Latvia
- Prior art keywords
- manufacture
- pharmaceutical composition
- substituted benzimidazoles
- benzimidazoles
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9002206A SE9002206D0 (sv) | 1990-06-20 | 1990-06-20 | New compounds |
| PCT/SE1991/000415 WO1991019711A1 (en) | 1990-06-20 | 1991-06-11 | Substituted benzimidazoles, process for their preparation and their pharmaceutical use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LV10953A true LV10953A (lv) | 1995-12-20 |
Family
ID=20379831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LV931045A LV10953A (lv) | 1990-06-20 | 1993-08-27 | Aizvietotie benzimidazoli to iegusanas panemiens pielietojums farmaceitiska kompozicija |
Country Status (27)
| Country | Link |
|---|---|
| EP (1) | EP0535081A1 (cs) |
| JP (1) | JPH05507713A (cs) |
| CN (1) | CN1058212A (cs) |
| AP (1) | AP215A (cs) |
| AU (1) | AU649453B2 (cs) |
| BG (1) | BG97200A (cs) |
| CA (1) | CA2083714A1 (cs) |
| CZ (1) | CZ279772B6 (cs) |
| FI (1) | FI925766A7 (cs) |
| HU (1) | HUT62881A (cs) |
| IE (1) | IE912025A1 (cs) |
| IL (1) | IL98470A0 (cs) |
| IS (1) | IS3721A7 (cs) |
| LT (2) | LT3952B (cs) |
| LV (1) | LV10953A (cs) |
| MA (1) | MA22199A1 (cs) |
| NO (1) | NO924775D0 (cs) |
| NZ (1) | NZ238546A (cs) |
| OA (1) | OA09682A (cs) |
| PT (1) | PT98035A (cs) |
| RO (1) | RO110493B1 (cs) |
| SE (1) | SE9002206D0 (cs) |
| TN (1) | TNSN91049A1 (cs) |
| TW (1) | TW216418B (cs) |
| WO (1) | WO1991019711A1 (cs) |
| YU (1) | YU104191A (cs) |
| ZA (2) | ZA914296B (cs) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9002043D0 (sv) * | 1990-06-07 | 1990-06-07 | Astra Ab | Improved method for synthesis |
| SE9103776D0 (sv) * | 1991-12-19 | 1991-12-19 | Astra Ab | New compounds |
| IS4232A (is) * | 1993-12-06 | 1995-06-07 | Astra Aktiebolag | Súbstitúerað bensimidasól, aðferðir við framleiðslu þess og lyfjafræðileg notkun |
| SE504459C2 (sv) * | 1994-07-15 | 1997-02-17 | Astra Ab | Förfarande för framställning av substituerade sulfoxider |
| SE9500422D0 (sv) * | 1995-02-06 | 1995-02-06 | Astra Ab | New oral pharmaceutical dosage forms |
| SE9500478D0 (sv) * | 1995-02-09 | 1995-02-09 | Astra Ab | New pharmaceutical formulation and process |
| SE9600070D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral pharmaceutical dosage forms |
| EP1257269B1 (en) | 2000-02-24 | 2004-11-03 | Kopran Research Laboratories Limited | Orally administrable acid stable anti-ulcer benzimidazole derivatives |
| SE0101379D0 (sv) | 2001-04-18 | 2001-04-18 | Diabact Ab | Komposition som hämmar utsöndring av magsyra |
| US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
| MXPA04009968A (es) | 2002-04-09 | 2004-12-13 | Flamel Tech Sa | Formulacion farmaceutica oral bajo forma de suspension acuosa de microcapsulas que permiten la liberacion modificada de principio (s) activo (s). |
| SE0203065D0 (sv) | 2002-10-16 | 2002-10-16 | Diabact Ab | Gastric acid secretion inhibiting composition |
| CA2540308C (en) | 2003-09-26 | 2013-08-06 | Alza Corporation | Drug coating providing high drug loading and methods for providing the same |
| TW200606163A (en) | 2004-04-22 | 2006-02-16 | Eisai Co Ltd | Imidazopyridine compound |
| US8541026B2 (en) | 2004-09-24 | 2013-09-24 | Abbvie Inc. | Sustained release formulations of opioid and nonopioid analgesics |
| US20070015782A1 (en) * | 2005-04-15 | 2007-01-18 | Eisai Co., Ltd. | Benzimidazole compound |
| US9040564B2 (en) | 2005-04-28 | 2015-05-26 | Eisai R&D Management Co., Ltd. | Stabilized composition |
| US7981908B2 (en) | 2005-05-11 | 2011-07-19 | Vecta, Ltd. | Compositions and methods for inhibiting gastric acid secretion |
| US7803817B2 (en) | 2005-05-11 | 2010-09-28 | Vecta, Ltd. | Composition and methods for inhibiting gastric acid secretion |
| WO2007122686A1 (ja) * | 2006-04-14 | 2007-11-01 | Eisai R & D Management Co., Ltd. | ベンズイミダゾール化合物 |
| ES2511792T3 (es) | 2006-07-25 | 2014-10-23 | Vecta Ltd. | Composiciones y métodos para la inhibición de la secreción de ácido gástrico usando derivados de pequeños ácidos dicarboxílicos en combinación con IBP |
| WO2008047681A1 (fr) * | 2006-10-13 | 2008-04-24 | Eisai R & D Management Co., Ltd. | Benzimidazole présentant une activité inhibitrice de la sécrétion d'acide gastrique |
| MX2011002515A (es) | 2008-09-09 | 2011-04-07 | Astrazeneca Ab | Metodo de administracion de una composicion farmaceutica a un paciente que lo necesita. |
| EA201290026A1 (ru) | 2009-06-25 | 2012-07-30 | Астразенека Аб | Способ лечения пациента, имеющего риск развития язвы, связанной с приемом нестероидных противовоспалительных средств (nsaid) |
| WO2011080500A2 (en) | 2009-12-29 | 2011-07-07 | Orexo Ab | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
| EP2519229A2 (en) | 2009-12-29 | 2012-11-07 | Novartis AG | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
| WO2011080502A2 (en) | 2009-12-29 | 2011-07-07 | Orexo Ab | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
| EP2601947A1 (en) | 2011-12-05 | 2013-06-12 | Abo Bakr Mohammed Ali Al-Mehdar | Fixed-dose combination for treatment of helicobacter pylori associated diseases |
| WO2013101897A2 (en) | 2011-12-28 | 2013-07-04 | Pozen Inc. | Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid |
| NZ779170A (en) * | 2016-09-14 | 2025-08-29 | Univ Nat Taiwan | Novel substituted benzimidazole derivatives as d-amino acid oxidase (daao) inhibitors |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE418966B (sv) | 1974-02-18 | 1981-07-06 | Haessle Ab | Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan |
| SE416649B (sv) | 1974-05-16 | 1981-01-26 | Haessle Ab | Forfarande for framstellning av foreningar som paverkar magsyrasekretionen |
| IN148930B (cs) | 1977-09-19 | 1981-07-25 | Hoffmann La Roche | |
| SE7804231L (sv) | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
| US4359465A (en) | 1980-07-28 | 1982-11-16 | The Upjohn Company | Methods for treating gastrointestinal inflammation |
| CH644116A5 (de) | 1980-08-21 | 1984-07-13 | Hoffmann La Roche | Imidazolderivate. |
| SE8300736D0 (sv) | 1983-02-11 | 1983-02-11 | Haessle Ab | Novel pharmacologically active compounds |
| SE8301182D0 (sv) | 1983-03-04 | 1983-03-04 | Haessle Ab | Novel compounds |
| IL75400A (en) * | 1984-06-16 | 1988-10-31 | Byk Gulden Lomberg Chem Fab | Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same |
| AU568441B2 (en) * | 1984-09-24 | 1987-12-24 | Upjohn Company, The | 2-(pyridylalkenesulfinyl) benzimidazole derivatives |
| IL76839A (en) * | 1984-10-31 | 1988-08-31 | Byk Gulden Lomberg Chem Fab | Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same |
| US4738975A (en) | 1985-07-02 | 1988-04-19 | Takeda Chemical Industries, Ltd. | Pyridine derivatives, and use as anti-ulcer agents |
| SE8505112D0 (sv) * | 1985-10-29 | 1985-10-29 | Haessle Ab | Novel pharmacological compounds |
| NZ222495A (en) | 1986-11-21 | 1991-04-26 | Haessle Ab | Benzimidazole derivatives and pharmaceutical compositions |
| DE3722810A1 (de) * | 1987-07-10 | 1989-01-19 | Hoechst Ag | Substituierte benzimidazole, verfahren zu deren herstellung, diese enthaltende pharmazeutische zubereitungen und deren verwendung |
| AU2621888A (en) * | 1987-10-30 | 1989-05-23 | Aktiebolaget Hassle | Omeprazole for treatment of diseases related to bone loss |
| ZA889194B (en) * | 1987-12-11 | 1989-08-30 | Byk Gulden Lomberg Chemisch Fa | Novel benzimidazole derivatives |
| AU3690289A (en) * | 1988-05-25 | 1989-12-12 | Byk Gulden Lomberg Chemische Fabrik Gmbh | New fluoralkoxy compounds |
-
1990
- 1990-06-20 SE SE9002206A patent/SE9002206D0/xx unknown
-
1991
- 1991-06-05 ZA ZA914296A patent/ZA914296B/xx unknown
- 1991-06-05 ZA ZA914297A patent/ZA914297B/xx unknown
- 1991-06-11 HU HU924033A patent/HUT62881A/hu unknown
- 1991-06-11 AU AU80097/91A patent/AU649453B2/en not_active Ceased
- 1991-06-11 WO PCT/SE1991/000415 patent/WO1991019711A1/en not_active Application Discontinuation
- 1991-06-11 JP JP91511435A patent/JPH05507713A/ja active Pending
- 1991-06-11 CA CA002083714A patent/CA2083714A1/en not_active Abandoned
- 1991-06-11 EP EP91911659A patent/EP0535081A1/en not_active Withdrawn
- 1991-06-11 RO RO92-01581A patent/RO110493B1/ro unknown
- 1991-06-12 TW TW080104582A patent/TW216418B/zh active
- 1991-06-12 YU YU104191A patent/YU104191A/sh unknown
- 1991-06-12 IL IL98470A patent/IL98470A0/xx unknown
- 1991-06-14 IE IE202591A patent/IE912025A1/en unknown
- 1991-06-14 NZ NZ238546A patent/NZ238546A/en unknown
- 1991-06-18 MA MA22462A patent/MA22199A1/fr unknown
- 1991-06-19 AP APAP/P/1991/000285A patent/AP215A/en active
- 1991-06-19 TN TNTNSN91049A patent/TNSN91049A1/fr unknown
- 1991-06-19 PT PT98035A patent/PT98035A/pt not_active Application Discontinuation
- 1991-06-20 CN CN91105024A patent/CN1058212A/zh active Pending
- 1991-06-20 CZ CS911894A patent/CZ279772B6/cs unknown
- 1991-06-20 IS IS3721A patent/IS3721A7/is unknown
-
1992
- 1992-11-27 OA OA60306A patent/OA09682A/en unknown
- 1992-12-10 NO NO924775A patent/NO924775D0/no unknown
- 1992-12-18 FI FI925766A patent/FI925766A7/fi not_active Application Discontinuation
- 1992-12-18 BG BG097200A patent/BG97200A/bg unknown
-
1993
- 1993-08-27 LV LV931045A patent/LV10953A/xx unknown
- 1993-12-30 LT LTIP1712A patent/LT3952B/lt not_active IP Right Cessation
- 1993-12-30 LT LTIP1713A patent/LT3977B/lt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| LTIP1713A (en) | 1995-08-25 |
| NO924775L (no) | 1992-12-10 |
| WO1991019711A1 (en) | 1991-12-26 |
| CA2083714A1 (en) | 1991-12-21 |
| AU649453B2 (en) | 1994-05-26 |
| IL98470A0 (en) | 1992-07-15 |
| IE912025A1 (en) | 1992-01-01 |
| NO924775D0 (no) | 1992-12-10 |
| EP0535081A1 (en) | 1993-04-07 |
| ZA914297B (en) | 1992-03-25 |
| LT3977B (en) | 1996-06-25 |
| LT3952B (en) | 1996-05-27 |
| IS3721A7 (is) | 1991-12-21 |
| AP9100285A0 (en) | 1991-07-31 |
| JPH05507713A (ja) | 1993-11-04 |
| CZ279772B6 (cs) | 1995-06-14 |
| HUT62881A (en) | 1993-06-28 |
| NZ238546A (en) | 1994-03-25 |
| OA09682A (en) | 1993-05-15 |
| MA22199A1 (fr) | 1992-04-01 |
| HU9204033D0 (en) | 1993-03-29 |
| ZA914296B (en) | 1992-03-25 |
| RO110493B1 (ro) | 1996-01-30 |
| TNSN91049A1 (fr) | 1992-10-25 |
| SE9002206D0 (sv) | 1990-06-20 |
| LTIP1712A (en) | 1995-08-25 |
| FI925766A0 (fi) | 1992-12-18 |
| TW216418B (cs) | 1993-11-21 |
| BG97200A (bg) | 1993-12-24 |
| YU104191A (sh) | 1994-01-20 |
| FI925766A7 (fi) | 1992-12-18 |
| CS189491A3 (en) | 1992-04-15 |
| AU8009791A (en) | 1992-01-07 |
| AP215A (en) | 1992-09-02 |
| CN1058212A (zh) | 1992-01-29 |
| PT98035A (pt) | 1992-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LV10953A (lv) | Aizvietotie benzimidazoli to iegusanas panemiens pielietojums farmaceitiska kompozicija | |
| FI925661L (fi) | Injicerbar farmaceutisk komposition | |
| FI913410A7 (fi) | Jatkuvasti vapauttavia farmaseuttisia koostumuksia | |
| DE122004000023I2 (de) | Pharmazeutische Zusammensetzung | |
| DE10199066I1 (de) | Pharmazeutische Zusammensetzung | |
| LV10082A (lv) | Propenskabes atvasinajumi to iegusanas panemiens sastavs un pielietosana senisu kukainu un ercu apkarosanai | |
| EE03108B1 (et) | Farmatseutiline kompositsioon | |
| FI981777L (fi) | Farmaseuttinen ainekoostumus | |
| SE8801813L (sv) | Pharmaceutical composition | |
| KR890701101A (ko) | 제약학적 조성물 | |
| KR880005932A (ko) | 신경중독손상을 감소시키기 위한 약제 조성물 | |
| FI922364A7 (fi) | Farmaseuttiset koostumukset | |
| FI901102A7 (fi) | Farmaseuttiset koostumukset | |
| DE4291156T1 (de) | Verbesserte pharmazeutische Zusammensetzungen | |
| BR8902337A (pt) | Composicao oral | |
| BG91785A (bg) | Лекарствена форма | |
| FI893643A7 (fi) | Farmaseuttisia koostumuksia | |
| BR8903994A (pt) | Composicao oral | |
| FI910088A7 (fi) | Oraalinen farmaseuttinen koostumus | |
| ITTO920303A0 (it) | "composizione farmaceutica antiinfiammatoria" | |
| UA26064A1 (uk) | Фармацевтичhа композиція | |
| DK0511991T3 (da) | Farmaceutisk formulering | |
| ATA133288A (de) | Pharmazeutische zusammensetzung | |
| FI910897A7 (fi) | (S)-norfluoksetiiniin liittyviä parannuksia | |
| FI915565L (fi) | Menetelmä paikalliseen käyttöön tarkoitettujen farmaseuttisten koostumusten valmistamiseksi |